+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Scleroderma, An Issue of Rheumatic Disease Clinics. The Clinics: Internal Medicine 41-3

  • ID: 3684663
  • Book
  • Elsevier Health Science
1 of 2

Scleroderma, or systemic sclerosis, is a chronic connective tissue disease generally classified as one of the autoimmune rheumatic diseases. Hardening of the skin is one of the most visible manifestations of the disease. It's estimated that about 300,000 Americans have scleroderma. About one third of those people have the systemic form of scleroderma. Since scleroderma presents with symptoms similar to other autoimmune diseases, diagnosis is difficult. This issue will cover: The Genetic Basis of SSc: Genetics, Epigenetics, Mechanisms of Pathogenesis - linking fibrosis, vasculopathy and immune dysregulation,  The Role of Autoantibodies in Diagnosis and Prognosis/survival, Managing Raynaud's phenomenon and ischemic ulcers
Managing SSc Lung Disease, Monitoring for and Managing Pulmonary Arterial Hypertension, and many more!

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 2


3 of 2
Mayes, Maureen D. Professor of Internal Medicine
Elizabeth Bidgood Chair in Rheumatology
Division of Rheumatology and Clinical Immunogenetics
University of Texas - Houston Medical School.
Note: Product cover images may vary from those shown